Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Holly Maples

Concepts (95)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vancomycin
8
2023
81
2.460
Why?
Methicillin-Resistant Staphylococcus aureus
7
2023
76
1.590
Why?
Anti-Bacterial Agents
12
2023
744
1.440
Why?
Staphylococcal Infections
7
2023
268
1.200
Why?
Area Under Curve
5
2021
182
0.420
Why?
Microbial Sensitivity Tests
4
2021
269
0.380
Why?
Pediatrics
2
2013
279
0.310
Why?
Triazoles
2
2005
108
0.280
Why?
Malaria
1
2006
37
0.270
Why?
Pyrimidines
2
2005
192
0.260
Why?
Drug Monitoring
3
2020
77
0.250
Why?
Antifungal Agents
2
2005
339
0.240
Why?
Referral and Consultation
1
2006
285
0.240
Why?
Trichosporon
1
2003
13
0.230
Why?
Child
11
2024
6847
0.230
Why?
Arthritis, Infectious
1
2024
44
0.220
Why?
Famotidine
1
2003
11
0.220
Why?
Histamine H2 Antagonists
1
2003
25
0.220
Why?
Osteomyelitis
1
2024
126
0.210
Why?
Mycoses
1
2003
157
0.210
Why?
Bacteremia
1
2023
90
0.210
Why?
Practice Guidelines as Topic
3
2020
449
0.200
Why?
Humans
19
2024
49974
0.200
Why?
Kidney Failure, Chronic
1
2003
198
0.190
Why?
Consensus
1
2021
148
0.180
Why?
Cystic Fibrosis
1
2022
147
0.180
Why?
Communicable Diseases
1
2020
55
0.170
Why?
Respiratory System
1
2015
26
0.130
Why?
Respiratory Tract Infections
1
2015
75
0.120
Why?
Tracheostomy
1
2015
75
0.120
Why?
Drug Utilization Review
1
2014
23
0.120
Why?
Inappropriate Prescribing
1
2013
18
0.110
Why?
United States
6
2020
4860
0.110
Why?
Drug Resistance, Bacterial
1
2013
71
0.110
Why?
Hospitals, Pediatric
1
2014
239
0.110
Why?
Infant
5
2015
3567
0.100
Why?
Pharmacists
2
2020
144
0.080
Why?
Plasmodium
1
2006
3
0.070
Why?
Specialization
1
2006
46
0.070
Why?
Geography
1
2006
61
0.070
Why?
Antimalarials
1
2006
23
0.070
Why?
Medicine
1
2006
56
0.070
Why?
Child, Preschool
4
2015
3871
0.060
Why?
Azithromycin
1
2005
25
0.060
Why?
Amphotericin B
1
2005
110
0.060
Why?
Antiretroviral Therapy, Highly Active
1
2004
34
0.060
Why?
Candidiasis
1
2005
114
0.060
Why?
HIV-1
1
2004
55
0.060
Why?
Treatment Refusal
1
2004
37
0.060
Why?
Mucorales
1
2024
11
0.060
Why?
Mucormycosis
1
2024
29
0.060
Why?
Micronesia
1
2024
107
0.060
Why?
Fatal Outcome
1
2003
195
0.050
Why?
Neutropenia
1
2003
116
0.050
Why?
Tissue Distribution
1
2003
163
0.050
Why?
Adolescent
3
2015
6356
0.050
Why?
Methicillin
1
2020
11
0.050
Why?
HIV Infections
1
2004
357
0.050
Why?
Societies, Pharmaceutical
1
2020
12
0.050
Why?
Staphylococcus aureus
1
2023
326
0.040
Why?
Aging
1
2005
687
0.040
Why?
Adult
1
2015
13236
0.040
Why?
Societies, Medical
1
2020
175
0.040
Why?
Lung
1
2022
486
0.040
Why?
Inflammation
1
2022
604
0.040
Why?
Acute Kidney Injury
1
2020
284
0.030
Why?
Pseudomonas Infections
1
2015
48
0.030
Why?
Pseudomonas aeruginosa
1
2015
72
0.030
Why?
Infusions, Intravenous
2
2005
206
0.030
Why?
Infant, Newborn
2
2015
2772
0.030
Why?
Feedback
1
2014
52
0.030
Why?
Government Regulation
1
2013
14
0.030
Why?
Infection Control
1
2013
50
0.030
Why?
Patient Safety
1
2013
102
0.030
Why?
Male
3
2024
25241
0.030
Why?
Data Collection
1
2014
279
0.030
Why?
Program Development
1
2013
166
0.030
Why?
Health Policy
1
2013
153
0.030
Why?
Female
3
2024
26472
0.030
Why?
Program Evaluation
1
2013
354
0.020
Why?
Animals
1
2006
13187
0.020
Why?
Prevalence
1
2014
944
0.020
Why?
Attitude of Health Personnel
1
2013
347
0.020
Why?
Retrospective Studies
2
2015
6108
0.020
Why?
Directly Observed Therapy
1
2004
8
0.020
Why?
Drug Resistance, Viral
1
2004
8
0.020
Why?
Foster Home Care
1
2004
14
0.020
Why?
Treatment Failure
1
2004
114
0.010
Why?
Viral Load
1
2004
76
0.010
Why?
RNA, Viral
1
2004
125
0.010
Why?
Chromatography, High Pressure Liquid
1
2005
349
0.010
Why?
Home Care Services
1
2004
73
0.010
Why?
Mass Spectrometry
1
2005
306
0.010
Why?
Child Abuse
1
2004
136
0.010
Why?
Infant, Premature
1
2005
318
0.010
Why?
Maples's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description